Heidi Fields's Trading History
| PHATPhathom Pharmaceuticals | May 21, 2026 | Director | Uninformative Buy | ― | $310.66K | |
| AAgilent | Mar 18, 2025 | Director | Uninformative Buy | 220.43K | $10.29M | |
| ICVXIcosavax | Feb 20, 2024 | ― | Uninformative Sell | ― | $0.00 | |
| AVNSAvanos Medical | Jan 06, 2021 | ― | Uninformative Buy | ― | $721.09K | |
| FNGNFinancial Engines | Jul 23, 2018 | ― | Uninformative Sell | 958.05K | $0.00 |
You May Also Like
Heidi Fields insider profile FAQ
What is the percentage of profitable transactions made by Heidi Fields?
The percentage of profitable transactions made by Heidi Fields is 15%.
What is the average return per transaction made by Heidi Fields?
The average return per transaction made by Heidi Fields is -19.10%.
What stocks does Heidi Fields hold?
Heidi Fields holds: PHAT, A, ICVX, FNGN, AVNS stocks.
What was Heidi Fields's most profitable transaction?
Heidi Fields’s most profitable transaction was an Informative Buy of A stock on November 5, 2015. The return on the trade was 5.00%.
What is Heidi Fields's role in Phathom Pharmaceuticals?
Heidi Fields's role in Phathom Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.